• SENSEX 73,246.03
    -352.64 (--0.48%)
  • BANKNIFTY 54,267.40
    292.50 (+0.54%)
  • Jio Platforms
    1,423.80 1,423.80(%)
  • NSE
    1,766.00 1,640.25(%)
  • Reliance Industries
    1,156.60 1,152.30(%)
  • Piramal Pharma
    235.45 235.45(%)
  • United Breweries
    1,316.00 1,845.90(%)
  • Larsen & Toubro
    3,892.00 4,440.00(%)
  • Billionbrains
    190.80 227.00(%)
  • Swiggy
    183.05 174.30(%)
  • Cholaman.Inv.&Fn
    1,557.55 1,952.00(%)
  • Syngene Intl.
    418.75 678.00(%)
  • HDFC Bank
    687.15 1,017.90(%)
  • Lenskart Solut.
    697.50 725.00(%)
  • HDFC AMC
    2,317.50 2,901.00(%)
  • Patanjali Foods
    375.20 613.95(%)
  • Ola Electric
    37.44 51.84(%)
  • One 97
    1,640.50 1,856.50(%)
  • Acutaas Chemical
    3,686.00 1,571.20(%)
  • Sahajanand Medi
    462.10 347.50(%)
  • Jubilant Ingrev.
    581.55 535.30(%)
  • FSN E-Commerce
    345.45 351.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Neuland Laboratories Ltd Pharmaceuticals - Indian - Bulk Drugs

  • Indian Private
  • BSE Code : 3800.0
  • ISIN : INE794A01010
19,970.00 655 (3.39%)
  • As on 28 Oct 2026 (EOD)

  • Today’s Low

    19,200.00

  • Today’s High

    20,095.00

  • Open

    19,200.00

  • Perv Close

    19,315.00

  • 52W Low

    11,500.00

  • 52W High

    24,225.00

Key Indicators

  • P/E(TTM)

    51.69

  • Mar.Cap (₹Cr.)

    25,621.29

  • Div & Yield %

    0.17

  • Book Value(₹)

    1,453.59

  • Debt-Equity Ratio

    3.39

  • AGM Date

    28-Oct-2026

  • EPS

    387.19

  • P/E Ratio

    51.69

Financials Ratios

  • Debt-Equity Ratio

    0.10

  • Mar.Cap (₹Cr.)

    25,621.29

  • RONW (%)

    26.38

  • ROCE (%)

    33.01

Score Board

  • Equity (₹ in Cr.)

    12.83

  • BV (₹)

    1,453.60

  • Sales( ₹ in Cr.)

    2,022.99

  • NP (in Cr.)

    360.22

  • NP Var(%)

    108.0

  • Div%

    340.0

  • CPS (₹)

    352.30

  • EPS (₹)

    280.80

  • Traded Value (₹ in Lakhs)

    25,679.86

  • 52 Week High

    24,225.00

  • 52 Week Low

    11,500.00

  • Price BSE

    20016.0

  • Price NSE

    19,970.00

  • Market Capital( in Cr.)

    25,679.86

  • P/C Ratio

    56.80

  • P/E Ratio

    71.30

  • Price Vs.BV

    280.80

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 2,022.99 1,476.84 1,558.58 1,191.20 951.08 936.91
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 2,022.99 1,476.84 1,558.58 1,191.20 951.08 936.91
Other Income 30.16 96.91 12.54 9.75 2.08 16.09
Stock Adjustments 64.26 -12.83 55.14 9.51 15.41 1.24
Total Income 2,117.41 1,560.92 1,626.26 1,210.46 968.57 954.24
EXPENDITURE :            
Raw Materials 823.89 578.45 636.49 491.98 441.79 443.04
Power and Fuel Cost 58.14 50.56 48.72 48.62 42.21 39.21
Employee Cost 328.82 261.40 248.53 194.84 175.76 144.02
Other Manufacturing Expenses 129.35 108.66 103.73 82.69 84.92 73.71
Selling and Administration Expenses 154.17 120.52 104.29 88.50 70.50 79.80
Miscellaneous Expenses 19.63 22.11 10.04 22.77 9.12 11.93
Employee Benefit Expenses 328.82 261.40 248.53 194.84 175.76 144.02
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 1,514.00 1,141.71 1,151.81 929.40 824.29 791.71
Operating Profit 603.41 419.22 474.47 281.06 144.27 162.54
Interest 23.95 8.30 14.00 13.07 13.49 17.90
Gross Profit 579.46 410.92 460.47 267.99 130.78 144.64
Depreciation 91.73 65.54 59.70 52.78 49.04 39.68
Profit Before Tax 487.73 345.38 400.77 215.21 81.74 104.96
Current Tax 128.88 73.65 99.59 50.39 20.42 12.48
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -4.26 12.29 1.59 1.70 -2.22 12.18
Reported Net Profit 363.11 259.43 299.60 163.12 63.53 80.29
Extraordinary Items 2.88 86.29 -0.30 -0.66 -1.36 9.81
Adjusted Net Profit 360.23 173.14 299.90 163.78 64.89 70.48
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 988.77 747.31 460.54 303.84 244.15 166.42
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 15.40 17.96 12.83 6.41 3.85 2.57
P & L Balance carried down 1,336.48 988.77 747.31 460.54 303.84 244.15
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 340.00 120.00 140.00 100.00 50.00 50.00
Dividend Per Share(Rs) 34.00 12.00 14.00 10.00 5.00 5.00
Earnings Per Share-Unit Curr 281.47 201.10 232.24 126.44 49.25 62.24
Earnings Per Share(Adj)-Unit Curr 281.47 201.10 232.24 126.44 49.25 62.24
Book Value 1,445.69 1,175.89 988.88 765.49 647.06 605.44
Book Value(Adj)-Unit Curr 1,445.69 1,175.89 988.88 765.49 647.06 605.44

Shareholding Pattern

  • Promoter Group

    32.26%

  • Public Share Holding

    67.74%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 200 200.00 200 200
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 200 0.00 200 2
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 805,561 6.28 805,561 12
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 3,333,352 25.98 3,333,352 1
Others 0 0.00 0 0
Sub Total 4,138,913 32.26 4,138,913 13
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 2,813,571 21.93 2,813,571 245
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 173,421 1.35 173,421 11
Mutual Funds / UTI 1,597,855 12.45 1,597,855 34
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 314,516 2.45 314,516 45
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 4,899,363 38.19 4,899,363 335
2] Non Institution
Bodies Corporate 618,965 4.82 618,165 876
Clearing Members 741 0.01 741 2
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 145,514 1.13 134,714 1,459
Foreign Non Institution Other 100 0.00 0 1
Hindu Undivided Families 74,900 0.58 73,900 1,185
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 863,573 6.73 863,573 9
Individuals holding nominal share capital up to Rs. 1 lakh 2,019,205 15.74 1,982,151 45,841
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 18,802 0.15 18,802 17
Others 49,613 0.39 49,613 1
Sub Total 3,791,413 29.55 3,741,659 49,391
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 12,829,889 100.00 12,780,135 49,741

Company Background

Neuland Laboratories LtdPharmaceuticals - Indian - Bulk Drugs

  • Neuland Laboratories Ltd
  • BSE Code : 3800.0
  • ISIN : INE794A01010

  • Incorporation Year

    1984

  • Registered Office

    11 Th Floor Phoenix IVY Buildi
    Plot No 573A-III Road No 82, Hyderabad,
    Telangana-500035

  • Telephone

    91-40-30211600

  • FAX

    91-40-30211602

  • Chairman

    D R Rao

  • Managing Director

    D Saharsh Rao

  • Company Secretary

    Sarada Bhamidipati

  • Auditor

    MSKA & Associates LLP

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    KFin Techologies Ltd
    Karvy Selenium Tow-B,
    31&32 Financial Dist,Nanakramguda
    Mumbai - Hyderabad-500032

Neuland Laboratories Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Neuland Labs. 20,015.65 2,053.15 2,022.99 51.69 26.50
Abbott India 26,278.90 7,217.19 6,929.05 34.58 43.78
Astrazeneca Phar 6,234.70 2,304.07 2,275.58 91.89 27.86
Glaxosmi. Pharma 2,496.65 3,932.76 3,790.20 39.88 58.17
Novartis India 1,805.95 393.10 354.33 45.60 15.94
Cipla 1,360.00 20,102.60 18,979.95 41.45 13.88
Bliss GVS Pharma 650.05 773.53 729.81 60.41 12.51
Amrutanjan Healt 491.10 520.13 502.55 26.30 24.16
Fermenta Biotec. 443.85 474.15 450.25 20.72 18.77
Guj. Themis Bio. 355.25 168.25 165.82 94.99 18.05
Ambalal Sarabhai 35.73 19.52 3.94 66.17 6.77